{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:22:34Z","timestamp":1790198554453,"version":"4.1.0"},"reference-count":161,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Disease-a-Month"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1016\/j.disamonth.2003.10.001","type":"journal-article","created":{"date-parts":[[2003,12,17]],"date-time":"2003-12-17T10:43:04Z","timestamp":1071657784000},"page":"696-741","source":"Crossref","is-referenced-by-count":75,"title":["Antiphospholipid syndrome"],"prefix":"10.1016","volume":"49","author":[{"given":"Sefer","family":"Gezer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.disamonth.2003.10.001_BIB1","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/00005792-198911000-00004","article-title":"The \u201cprimary\u201d antiphospholipid syndrome","volume":"68","author":"Asherson","year":"1989","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB2","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0025-7125(16)30151-1","article-title":"Hypercoagulability and thrombosis","volume":"78","author":"Bick","year":"1994","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB3","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0925-5710(96)00550-6","article-title":"Antiphospholipid thrombosis syndromes","volume":"65","author":"Bick","year":"1997","journal-title":"Int J Hematol"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB4","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1146\/annurev.med.54.101601.152412","article-title":"The antiphospholipid syndrome","volume":"54","author":"Rand","year":"2003","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/107602960100700401","article-title":"Antiphospholipid thrombosis syndrome","volume":"7","author":"Bick","year":"2001","journal-title":"Clin Appl Thromb Haemost"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB6","first-page":"621","article-title":"A hemorrhagic disorder caused by circulating anticoagulant in patients with disseminated lupus erythematosus","volume":"31","author":"Conley","year":"1952","journal-title":"J Clin Invest"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB7","first-page":"416","article-title":"Thrombosis in systemic lupus erythematosus despite circulating anticoagulants","volume":"62","author":"Bowie","year":"1963","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB8","first-page":"75","article-title":"Acquired inhibitors of blood coagulation","volume":"1","author":"Feinstein","year":"1972","journal-title":"Prog Hemost Thromb"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB9","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.0954-6820.1975.tb04897.x","article-title":"Intrauterine death and circulating anticoagulant \u201cantithromboplastin\u201d","volume":"197","author":"Nilsson","year":"1975","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB10","first-page":"285","article-title":"The anticardiolipin syndrome [editorial]","volume":"3","author":"Hughes","year":"1985","journal-title":"Clin Exp Rheumatol"},{"issue":"suppl 14","key":"10.1016\/j.disamonth.2003.10.001_BIB11","first-page":"208","article-title":"Antiphospholipid antibodies","volume":"13","author":"Harris","year":"1987","journal-title":"J Rheumatol"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB12","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJMra002974","article-title":"The antiphospholipid syndrome","volume":"346","author":"Levine","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB13","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1006\/jaut.2000.0409","article-title":"Epidemiology of the antiphospholipid antibody syndrome","volume":"15","author":"Petri","year":"2000","journal-title":"J Autoimmun"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB14","first-page":"175","article-title":"A prospective epidemiological study on the occurrence of antiphospholipid antibody","volume":"24","author":"Schved","year":"1994","journal-title":"Hemostasis"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1055\/s-0038-1648840","article-title":"Prevalence follow-up and clinical significance of the anticardiolipin antibodies in normal subjects","volume":"72","author":"Vila","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB16","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1055\/s-2007-1002434","article-title":"Deep vein thrombosis","volume":"18","author":"Bick","year":"1992","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB17","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0002-9343(96)00335-X","article-title":"The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases","volume":"101","author":"Merkel","year":"1996","journal-title":"Am J Med"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB18","first-page":"113","article-title":"Systemic lupus erythematosus","volume":"72","author":"Cervera","year":"1993","journal-title":"The European Working Party on Systemic Lupus Erythematosus. Medicine"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB19","doi-asserted-by":"crossref","first-page":"682","DOI":"10.7326\/0003-4819-112-9-682","article-title":"Antiphospholipid antibodies","volume":"112","author":"Love","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB20","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0049-0172(92)90021-5","article-title":"Preliminary classification criteria for antiphospholipid syndrome within systemic lupus erytematosus","volume":"21","author":"Alarc\u00f3n-Segovia","year":"1992","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB21","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1177\/096120339200100201","article-title":"Cofactors involved in the antiphospholipid syndrome [editorial]","volume":"1","author":"Bevers","year":"1992","journal-title":"Lupus"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB22","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1182\/blood.V83.10.2878.2878","article-title":"Functional and binding studies of the roles of prothrombin and beta-2-glycoprotein I in the expression of lupus anticoagulant activity","volume":"83","author":"Permpikul","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB23","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(83)91267-9","article-title":"Anticardiolipin antibodies","volume":"2","author":"Harris","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB24","first-page":"1173","article-title":"MHC studies of the primary antiphospholipid antibody syndrome and of antiphospholipid antibodies in systemic lupus erythematosus","volume":"23","author":"Goldstein","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB25","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1006\/jaut.2000.0412","article-title":"Endothelial activation by aPL","volume":"15","author":"Meroni","year":"2000","journal-title":"J Autoimmun"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB26","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1177\/096120339400300503","article-title":"Antiphospholipid antibodies, thrombosis and atherosclerosis in systemic lupus erythematosus","volume":"3","author":"Ames","year":"1994","journal-title":"Lupus"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB27","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1182\/blood.V81.10.2618.2618","article-title":"Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S","volume":"81","author":"Oosting","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB28","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1177\/096120339400300401","article-title":"Beta-2-glycoprotein I","volume":"3","author":"Kandiah","year":"1994","journal-title":"Lupus"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB29","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1055\/s-0038-1646452","article-title":"The relationship of antiphospholipid antibodies to thromboembolic disease in systemic lupus erythematosus","volume":"66","author":"Long","year":"1991","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB30","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2214\/ajr.170.2.9456930","article-title":"Systemic thrombosis in patients with antiphospholipid antibodies","volume":"170","author":"Provenzale","year":"1998","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0002-9343(94)90108-2","article-title":"Comparison of the primary and secondary antiphospholipid syndrome","volume":"96","author":"Vianna","year":"1994","journal-title":"Am J Med"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB32","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0889-8588(18)30275-2","article-title":"Anticardiolipin antibodies and thrombosis","volume":"6","author":"Bick","year":"1992","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB33","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1055\/s-2007-994935","article-title":"Antiphospholipid syndrome and thrombosis","volume":"25","author":"Bick","year":"1999","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB34","doi-asserted-by":"crossref","first-page":"997","DOI":"10.7326\/0003-4819-117-12-997","article-title":"Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis","volume":"117","author":"Ginsburg","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB35","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1136\/bmj.287.6398.1021","article-title":"Thrombosis in systemic lupus erythematosus","volume":"287","author":"Boey","year":"1983","journal-title":"Br Med J"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB36","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1001\/archinte.1984.00350150102029","article-title":"Thromboembolism in patients with the \u201clupus-like\u201d-type circulating anticoagulant","volume":"144","author":"Elias","year":"1984","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB37","first-page":"846","article-title":"Occlusive retinal vascular disease in systemic lupus erytematosus","volume":"11","author":"Hall","year":"1984","journal-title":"J Rheumatol"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB38","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00001721-199606000-00011","article-title":"Thromboembolic disease developing during oral contraceptive therapy in young females with antiphospholipid antibodies","volume":"7","author":"Girolami","year":"1996","journal-title":"Blood Coagulation Fibrinolysis"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB39","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1191\/096120398678919967","article-title":"Familial coexistence of primary antiphospholipid syndrome and factor V Leiden","volume":"7","author":"Schutt","year":"1998","journal-title":"Lupus"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB40","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0272-6386(96)90109-2","article-title":"Renal infarction and thrombosis of the infrarenal aorta in a 35-year-old man with primary antiphospholipid syndrome","volume":"27","author":"Poux","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB41","doi-asserted-by":"crossref","first-page":"528","DOI":"10.2169\/internalmedicine.36.528","article-title":"Antiphospholipid syndrome complicated by thrombosis of the superior mesenteric artery","volume":"36","author":"Kojima","year":"1997","journal-title":"Intern Med"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB42","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1212\/WNL.40.8.1190","article-title":"Antiphospholipid antibodies and cerebral ischemia in young people","volume":"40","author":"Brey","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB43","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1161\/01.STR.29.9.1759","article-title":"High prevalence of antiphosphatidylinositol antibodies in young patients with cerebral ischemia of undetermined cause","volume":"29","author":"Toschi","year":"1998","journal-title":"Stroke"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB44","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1161\/01.STR.23.2.189","article-title":"Lupus anticoagulant and anticardiolipin antibodies in young adults with cerebral ischemia","volume":"23","author":"Nencini","year":"1992","journal-title":"Stroke"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB45","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/ana.410250303","article-title":"Neurological diseases associated with antiphospholipid antibodies","volume":"25","author":"Briley","year":"1989","journal-title":"Ann Neurol"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB46","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/0899-7071(95)00044-5","article-title":"The neuroimaging features of the cardiolipin antibody syndrome","volume":"21","author":"Weingarten","year":"1997","journal-title":"Clin Imag"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB47","doi-asserted-by":"crossref","unstructured":"Anticardiolipin antibodies are an independent risk factor for first ischemic stroke. The Antiphospholipid Antibodies in Stroke Study (APASS) Group. Neurology 1993;43:2069-73","DOI":"10.1212\/WNL.43.10.2069"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB48","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1161\/01.STR.28.12.2363","article-title":"Cerebral venous thrombosis and anticardiolipin antibodies","volume":"28","author":"Carhuapoma","year":"1997","journal-title":"Stroke"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB49","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1212\/WNL.39.8.1138","article-title":"Sneddon's syndrome","volume":"39","author":"Asherson","year":"1989","journal-title":"Neurology"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB50","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0165-5728(88)90042-2","article-title":"Severe Guillain-Barr\u00e9 syndrome","volume":"19","author":"Frampton","year":"1988","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB51","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1001\/archneur.1987.00520200078024","article-title":"The spectrum of neurologic disease associated with anticardiolipin antibodies","volume":"44","author":"Levin","year":"1987","journal-title":"Arch Neurol"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB52","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1017\/S0317167100036064","article-title":"Optic neuritis and myelopathy in systemic lupus erytematosus","volume":"13","author":"Oppenheimer","year":"1986","journal-title":"Can Neurol Sci"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB53","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/BF02030977","article-title":"Arterial occlusion causing large bowel infarction","volume":"5","author":"Asherson","year":"1986","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB54","first-page":"174","article-title":"Superior mesenteric artery thrombosis associated with antiphospholipid syndrome","volume":"155","author":"Hamilton","year":"1991","journal-title":"West J Med"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB55","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/art.1780280525","article-title":"Aortic arch syndrome associated with anticardiolipin antibodies and the lupus anticoagulant","volume":"28","author":"Asherson","year":"1985","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB56","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/BF02030977","article-title":"Arterial occlusion causing large bowel infarction","volume":"5","author":"Asherson","year":"1986","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB57","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1136\/hrt.56.2.190","article-title":"Myocardial infarction in a young male with systemic lupus erythematosus, deep vein thrombosis and antiphospholipid antibodies","volume":"56","author":"Asherson","year":"1986","journal-title":"Br Heart J"},{"issue":"suppl 2","key":"10.1016\/j.disamonth.2003.10.001_BIB58","doi-asserted-by":"crossref","first-page":"S132","DOI":"10.1177\/096120339800700229","article-title":"Antiphospholipid antibodies and myocardial infarction","volume":"7","author":"Vaarala","year":"1998","journal-title":"Lupus"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB59","doi-asserted-by":"crossref","unstructured":"Gavaghan TP, Krilis SA, Daggard GE, Baron DW, Hickie JB, Chesterman CN. Anticardiolipin antibodies and occlusion of coronary artery bypass grafts. 1987;2:977-8","DOI":"10.1016\/S0140-6736(87)91470-X"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB60","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0140-6736(86)92004-0","article-title":"Coronary artery bypass graft failure","volume":"2","author":"Morton","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB61","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3109\/08916939809003861","article-title":"Antiphospholipid antibodies","volume":"27","author":"Ludia","year":"1998","journal-title":"Autoimmunity"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB62","doi-asserted-by":"crossref","first-page":"293","DOI":"10.7326\/0003-4819-116-4-293","article-title":"Valvular heart disease in primary antiphospholipid syndrome","volume":"116","author":"Galve","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB63","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0002-9343(89)90337-9","article-title":"Aortic insufficiency and mitral regurgitation in patients with systemic lupus erythematosus and the antiphospholipd syndrome","volume":"86","author":"Chartash","year":"1989","journal-title":"Am J Med"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB64","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0002-9343(89)90337-9","article-title":"Aortic insufficiency and mitral regurgitation in patients with systemic lupus erythematosus and the antiphospholipid syndrome","volume":"86","author":"Chartash","year":"1989","journal-title":"Am J Med"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB65","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0002-9343(90)90368-N","article-title":"Association between antiphospholipid antibodies and cardiac abnormalities in patients with systemic lupus erythematosus","volume":"89","author":"Leung","year":"1990","journal-title":"Am J Med"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB66","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0049-0172(97)80034-0","article-title":"Valvular dysfunction in antiphospholipid syndrome","volume":"27","author":"Nesher","year":"1997","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB67","doi-asserted-by":"crossref","first-page":"294","DOI":"10.4065\/78.3.294","article-title":"Antiphospholipid antibodies and the risk of thromboembolic events in valvular heart disease","volume":"78","author":"Bulckaen","year":"2003","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB68","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1046\/j.1523-1755.2002.00500.x","article-title":"\u201cBlack swan in the kidney:\u201d","volume":"62","author":"Nzerue","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB69","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1517\/13543784.11.6.819","article-title":"Nephrological and obstetric complications of the antiphospholipid syndrome","volume":"11","author":"Isom","year":"2002","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB70","first-page":"446","article-title":"Antiphospholipid syndrome nephropathy","volume":"15","author":"Nochy","year":"2002","journal-title":"J Nephrol"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB71","first-page":"342","article-title":"Up-date on the antiphospholipid syndrome","volume":"15","author":"Luzzana","year":"2002","journal-title":"J Nephrol"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB72","first-page":"286","article-title":"High prevalence of antiphospholipid antibodies in precapillary pulmonary hypertension","volume":"23","author":"Karmochkine","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB73","doi-asserted-by":"crossref","first-page":"912","DOI":"10.2169\/internalmedicine.35.912","article-title":"Asymptomatic pulmonary hypertension complicated with antiphospholipid syndrome case","volume":"35","author":"Miyashita","year":"1996","journal-title":"Intern Med"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB74","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1378\/chest.112.6.1707","article-title":"Antiphospholipid antibody syndrome presenting as a refractory noninflammatory pulmonary vasculopathy","volume":"112","author":"Kerr","year":"1997","journal-title":"Chest"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB75","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/j.1440-1746.1997.tb00378.x","article-title":"Mesenteric and portal venous obstruction associated with primary antiphospholipid antibody syndrome","volume":"12","author":"Lee","year":"1997","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB76","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0022-2143(98)90096-8","article-title":"Prevalence of antiphospholipid antibodies in patients with chronic liver disease related to alcohol or hepatitis C virus","volume":"131","author":"Biron","year":"1998","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB77","first-page":"345","article-title":"Severe bleeding due to acquired hypoprothrombinemia-lupus anticoagulant syndrome","volume":"82","author":"Vivaldi","year":"1997","journal-title":"Haematologica"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB78","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1177\/096120339700600110","article-title":"Catastrophic haemorrhage in a case of paediatric primary antiphospholipid syndrome and factor II deficiency","volume":"6","author":"Hudson","year":"1997","journal-title":"Lupus"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB79","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1136\/ard.56.3.194","article-title":"Thrombocytopenia in the antiphospholipid syndrome","volume":"56","author":"Cuadrado","year":"1997","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB80","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1046\/j.1365-2141.1997.2243038.x","article-title":"Anti-platelet antibodies in patients with systemic lupus erythematosus and the primary antiphospholipid antibody syndrome","volume":"98","author":"Macchi","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB81","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1136\/pgmj.62.734.1081","article-title":"Anticardiolipin antibodies","volume":"62","author":"Asherson","year":"1986","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB82","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1001\/archderm.1987.01660290064017","article-title":"Livido reticularis associated with increased titers of anticardiolipin antibodies in systemic lupus erythematosus","volume":"123","author":"Weinstein","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB83","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1055\/s-2007-1001891","article-title":"Cutaneous expressions of antiphospholipid syndrome","volume":"20","author":"Eng","year":"1994","journal-title":"Semin Thromb Heamost"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB84","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1001\/archderm.1991.01680100143034","article-title":"Widespread cutaneous necrosis in a patient with rheumatoid arthritis associated with anticardiolipin antibodies","volume":"127","author":"Wolf","year":"1991","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB85","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/00006254-199406000-00026","article-title":"The immunobiology and obstetrical consequences of antiphospholipid antibodies","volume":"49","author":"Lockwood","year":"1994","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB86","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1046\/j.1365-2141.2000.02069.x","article-title":"Guidelines on the investigation and management of the antiphospholipid syndrome","volume":"109","author":"Greaves","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB87","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1177\/107602960100700402","article-title":"Thrombophilia and pregnancy","volume":"7","author":"Arkel","year":"2001","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB88","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s11926-002-0081-2","article-title":"The relation between antiphospholipid syndrome-related pregnancy morbidity and non-gravid vascular thrombosis","volume":"4","author":"Erkan","year":"2002","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB89","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/S0029-7844(03)00363-6","article-title":"Antiphospholipid syndrome","volume":"101","author":"Branch","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB90","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1056\/NEJM198507183130304","article-title":"Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus","volume":"313","author":"Lockshin","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB91","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/0029-7844(95)00498-X","article-title":"Antiphospholipid antibodies and fetal death","volume":"87","author":"Oshiro","year":"1996","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB92","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/S0002-9378(12)90741-3","article-title":"Should anticardiolipin tests be performed in otherwise healthy pregnant women?","volume":"165","author":"Harris","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB93","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1182\/blood.V80.4.859.859","article-title":"Lupus anticoagulant, anticardiolipin antibodies, fetal loss and systemic lupus erythematosus","volume":"80","author":"Feinstein","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB94","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/1529-0131(200001)43:1<140::AID-ANR18>3.0.CO;2-P","article-title":"Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta 2-glycoprotein I","volume":"43","author":"di Somone","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB95","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJM199707173370303","article-title":"Pregnancy loss in the antiphospholipid-antibody syndrome","volume":"337","author":"Rand","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB96","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1055\/s-0037-1613963","article-title":"Ontogeny of beta2-glycoprotein I and annexin V in villous placenta of normal and antiphospholipid pregnancies","volume":"84","author":"Donohoe","year":"2000","journal-title":"Thromb Haemost"},{"issue":"suppl 2","key":"10.1016\/j.disamonth.2003.10.001_BIB97","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1177\/096120339800700214","article-title":"The catastrophic antiphospholipid syndrome, 1998","volume":"7","author":"Asherson","year":"1998","journal-title":"Lupus"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB98","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/00005792-199805000-00005","article-title":"Catastrophic antiphospholipid syndrome","volume":"77","author":"Asherson","year":"1998","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB99","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0749-0704(02)00026-X","article-title":"Catastrophic antiphospholipid syndrome in the intensive care unit","volume":"18","author":"Westney","year":"2002","journal-title":"Crit Care Clin"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB100","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/00005792-200303000-00005","article-title":"Adrenal involvement in the antiphospholipid syndrome","volume":"82","author":"Espinosa","year":"2003","journal-title":"Medicine"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB101","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0002-9343(98)00061-8","article-title":"Thrombotic storm","volume":"104","author":"Kitchens","year":"1998","journal-title":"Am J Med"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB102","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1365-2141.1988.tb06206.x","article-title":"Anticardiolipin antibodes in HIV infected patients with or without immune thrombocytopenic purpura","volume":"67","author":"Intrator","year":"1988","journal-title":"Br J Haematol"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB103","first-page":"214","article-title":"Human immunodeficiency virus infection, antiphospholipid antibodies, and the antiphospholipid syndrome [editorial]","volume":"30","author":"Asherson","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB104","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1365-2141.1987.tb04157.x","article-title":"Anticardiolipin antibodies associated with HTLV-III infection","volume":"65","author":"Canoso","year":"1987","journal-title":"Br J Haematol"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB105","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1055\/s-0038-1646531","article-title":"Anticardiolipin antibodies are elevated in HIV-1 infected haemophiliacs but do not predict for disease progression","volume":"61","author":"Panzer","year":"1989","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB106","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1001\/archinte.1989.00390080091020","article-title":"Anticardiolipin antibodies in acquired immune deficiency syndrome","volume":"149","author":"Stimmler","year":"1989","journal-title":"Arch intern Med"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB107","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/0090-1229(86)90046-2","article-title":"Anticardiolipin response in acute infections","volume":"41","author":"Vaarala","year":"1986","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB108","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1055\/s-0038-1645192","article-title":"Dilute aPTT prolongation by antiphospholipid antibodies in patients with liver cirrhosis","volume":"63","author":"Violi","year":"1990","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB109","first-page":"719","article-title":"Concurrent lupus anticoagulants and prothrombin deficiency due to phenytoin use","volume":"111","author":"Harrison","year":"1987","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB110","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/ajcp\/93.6.771","article-title":"Heterogeneity of laboratory test results for antiphospholipid antibodies in patients treated with chlorpromazine and other phenothiazines","volume":"93","author":"Lillicrap","year":"1990","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB111","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F","article-title":"International consensus statement on preliminary classification criteria for definitive antiphospholipid syndrome","volume":"42","author":"Wilson","year":"1999","journal-title":"Atrhritis Rheum"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB112","first-page":"1185","article-title":"Criteria for the diagnosis of lupus anticoagulants","volume":"74","author":"Brandt","year":"1995","journal-title":"On behalf of the Subcommittee on Lupus Anticoagulant\/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB113","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00005792-198911000-00003","article-title":"Antiphospholipid antibodies and antiphospholipid syndrome in systemic lupus erythematosus","volume":"68","author":"Alarc\u00f3n-Segovia","year":"1989","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB114","first-page":"482","article-title":"Primary antiphospholipid syndrome","volume":"16","author":"Alarc\u00f3n-Segovia","year":"1989","journal-title":"J Rheumatol"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB115","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/0046-8177(95)90218-X","article-title":"Spectrum of vascular pathology affecting patients with antiphospholipid syndrome","volume":"26","author":"Hughson","year":"1995","journal-title":"Hum Pathol"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB116","series-title":"The antiphospholipid syndrome","first-page":"89","article-title":"Pathology of antiphospholipid syndrome","author":"Lie","year":"1996"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB117","series-title":"Practical hematology","first-page":"298","article-title":"Investigation of hemostasis","author":"Laflan","year":"1995"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB118","series-title":"Disorders of hemostasis and thrombosis","author":"Hathaway","year":"1993"},{"issue":"suppl 2","key":"10.1016\/j.disamonth.2003.10.001_BIB119","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1177\/096120339800700209","article-title":"Prothrombin as cofactor for antiphospholipids","volume":"7","author":"Galli","year":"1998","journal-title":"Lupus"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB120","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1182\/blood.V86.2.617.bloodjournal862617","article-title":"Kaolin clotting time and dilute Russell's viper venom time distinguish between prothrombin-dependent and beta 2-glycoprotein I-dependent antiphospholipid antibodies","volume":"86","author":"Galli","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB121","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1365-2141.1994.tb04876.x","article-title":"Optimization of the dilute prothrombin time for the detection of lupus anticoagulant by use of a recombinant human tissue thromboplastin","volume":"87","author":"Arnout","year":"1994","journal-title":"Br J Heamatol"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB122","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2141.1989.tb07687.x","article-title":"The reappraisal of dilute tissue thromboplastin inhibition test in the diagnosis of lupus anticoagulant","volume":"72","author":"Liu","year":"1989","journal-title":"Br J Haematol"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB123","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1055\/s-0038-1648949","article-title":"Evaluation of recently described tests for detection of the lupus anticoagulant","volume":"72","author":"Forastiero","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB124","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0022-2143(97)90004-4","article-title":"Prevalence and clinical significance of IgG isotype anti-beta 2-glycoprotein I antibodies in antiphospholipid syndrome","volume":"129","author":"Sanmarco","year":"1997","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB125","doi-asserted-by":"crossref","unstructured":"Zanon E, Prandoni P, Vianello F, Saggiorato G, Carraro G, Bagatella P, et al. Anti-beta2-glycoprotein I antibodies in patients with acute venous thromboembolism: prevalence and association with recurrent thromboembolism. Thromb Res 1999;96:269-74","DOI":"10.1016\/S0049-3848(99)00105-X"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB126","doi-asserted-by":"crossref","unstructured":"Hajjar KA, Jacovina AT, Chacko J. An endothelial cell receptor for plasminogen\/tissue plasminogen activator. I: Identity with annexin II. J Biol Chem 1994;269:21191-7","DOI":"10.1016\/S0021-9258(17)31947-6"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB127","doi-asserted-by":"crossref","unstructured":"Cesarman GM, Guevara CA, Hajjar KA. An endothelial cell receptor for plasminogen\/tissue plasminogen activator (t-PA). II: Annexin II-mediated enhancement of t-PA-dependent plasminogen activation. J Biol Chem 1994;269:21198-203","DOI":"10.1016\/S0021-9258(17)31948-8"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB128","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1056\/NEJM198605223142118","article-title":"Anticardiolipin antibodies in pregnant patients with systemic lupus erythematosus [letter]","volume":"314","author":"Lenzi","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB129","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1177\/096120339600500602","article-title":"Antiphospholipid antibody associated thrombosis","volume":"5","author":"McCrae","year":"1996","journal-title":"Lupus"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB130","first-page":"2136","article-title":"Antiphospholipid antibodies syndrome","volume":"126","author":"Urfer","year":"1996","journal-title":"Schweiz Med Wochenschr"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB131","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1002\/1529-0131(200106)44:6<1466::AID-ART242>3.0.CO;2-C","article-title":"High thrombosis rate after fetal loss in antiphospholipid syndrome","volume":"44","author":"Erkan","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"suppl 1","key":"10.1016\/j.disamonth.2003.10.001_BIB132","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1177\/096120339600500105","article-title":"Hydroxychloroquine use in the Baltimore Lupus Cohort","volume":"5","author":"Petri","year":"1996","journal-title":"Lupus"},{"issue":"suppl 1","key":"10.1016\/j.disamonth.2003.10.001_BIB133","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1177\/096120339600500113","article-title":"The use of chloroquine and hydroxychloroquine for non-infectious conditions other than rheumatoid arthritis or lupus","volume":"5","author":"Wallace","year":"1996","journal-title":"Lupus"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB134","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJM199504133321504","article-title":"The management of thrombosis in the antiphospholipid-antibody syndrome","volume":"332","author":"Khamashta","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB135","doi-asserted-by":"crossref","first-page":"303","DOI":"10.7326\/0003-4819-117-4-303","article-title":"Antiphospholipid thrombosis","volume":"117","author":"Rosove","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB136","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1136\/ard.52.9.689","article-title":"Patients with antiphospholipid antibodies and venous thrombosis should receive long term anticoagulant treatment","volume":"52","author":"Derksen","year":"1993","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB137","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1182\/blood.V86.10.3685.bloodjournal86103685","article-title":"Antiphospholipid antibodies and venous thromboembolism","volume":"86","author":"Ginsberg","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB138","first-page":"332","article-title":"Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy","volume":"104","author":"Schulman","year":"1998","journal-title":"Duration of Anticoagulation Study Group. Am J Med"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB139","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1055\/s-0037-1614324","article-title":"The effects of low-intensity warfarin on coagulation activation in patients with antiphospholipid antibodies and systemic lupus erythematosus","volume":"82","author":"Douketis","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB140","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S0002-9343(96)00060-5","article-title":"Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies","volume":"100","author":"Finazzi","year":"1996","journal-title":"Am J Med"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB141","doi-asserted-by":"crossref","first-page":"177","DOI":"10.7326\/0003-4819-127-3-199708010-00001","article-title":"Monitoring warfarin therapy in patients with lupus anticoagulants","volume":"127","author":"Moll","year":"1997","journal-title":"Ann Intern Med"},{"issue":"suppl 1","key":"10.1016\/j.disamonth.2003.10.001_BIB142","first-page":"10","article-title":"Potential failure of the international normalized ratio (INR) system in the monitoring of oral anticoagulation in patients with lupus anticoagulants","volume":"147","author":"Della Valle","year":"1996","journal-title":"Ann Med Interne (Paris)"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB143","doi-asserted-by":"crossref","first-page":"552","DOI":"10.7326\/0003-4819-120-7-199404010-00004","article-title":"The international normalized ratio (INR) for monitoring warfarin therapy","volume":"120","author":"Le","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB144","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0049-3848(80)90022-5","article-title":"Multicenter evaluation of a new chromogenic factor X assay in plasma of patients on oral anticoagulants","volume":"19","author":"Ciavarella","year":"1980","journal-title":"Thromb Res"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB145","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/00001721-199701000-00008","article-title":"Plasma levels of factors II, VII and X and their relationship to the international normalized ratio during chronic warfarin therapy","volume":"8","author":"Lind","year":"1997","journal-title":"Blood Coagulation Fibrinoloysis"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB146","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1177\/096120339600500613","article-title":"Fibrinolytic treatment in primary antiphospholipid syndrome","volume":"5","author":"Camps Garcia","year":"1996","journal-title":"Lupus"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB147","unstructured":"Julkunen H, Hedman C, Kauppi M. Thrombolysis for acute ischemic stroke in the primary antiphospholipid syndrome. J Rheumatol 24:181-3"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB148","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1159\/000177119","article-title":"Successful treatment of acute myocardial infarction by thrombolytic therapy in a patient with primary antiphospholipid antibody syndrome","volume":"87","author":"Ho","year":"1996","journal-title":"Cardiology"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB149","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/0002-9378(92)91596-3","article-title":"Repeated fetal losses associated with antiphospholipid antibodies","volume":"166","author":"Cowchock","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB150","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/S0002-9378(96)70610-5","article-title":"Antiphospholipid antibody-associated recurrent pregnancy loss","volume":"174","author":"Kutteh","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB151","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/bmj.314.7076.253","article-title":"Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)","volume":"314","author":"Rai","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB152","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1067\/mob.2000.106754","article-title":"Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome?","volume":"183","author":"Pattison","year":"2000","journal-title":"a randomized controlled trial. Am J Obstet Gynecol"},{"issue":"suppl 1","key":"10.1016\/j.disamonth.2003.10.001_BIB153","doi-asserted-by":"crossref","first-page":"S122","DOI":"10.1378\/chest.119.1_suppl.122S","article-title":"Use of antithrombotic agents during pregnancy","volume":"119","author":"Ginsberg","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB154","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1055\/s-0037-1614550","article-title":"Safety of low-molecular-weight heparin in pregnancy","volume":"81","author":"Sanson","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB155","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1055\/s-0038-1646558","article-title":"Risks to the fetus of anticoagulant therapy during pregnancy","volume":"61","author":"Ginsberg","year":"1989","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB156","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1001\/archinte.1989.00390100059015","article-title":"Heparin therapy during pregnancy","volume":"149","author":"Ginsberg","year":"1989","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB157","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/0029-7844(95)00452-1","article-title":"Low molecular weight heparin during pregnancy and delivery","volume":"87","author":"Dulitzki","year":"1996","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB158","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0002-9378(99)70091-8","article-title":"Changes in the pharmacokinetics of the low molecular weight heparin enoxaparin sodium during pregnancy","volume":"181","author":"Casele","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB159","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1055\/s-0038-1655903","article-title":"Thromboprophylaxis with low molecular weight heparin (Fragmin) in high risk pregnancies","volume":"77","author":"Hunt","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB160","first-page":"1","article-title":"Thromboprophylaxis with low molecular mass heparin, \u201cFragmin\u201d (dalteparin), during pregnancy","volume":"9","author":"Blomback","year":"1998","journal-title":"Blood Coagulation Fibrinolysis"},{"key":"10.1016\/j.disamonth.2003.10.001_BIB161","first-page":"1099","article-title":"Do low-risk pregnant women with antiphospholipid antibodies need to be treated?","volume":"176","author":"Cowchock","year":"1997","journal-title":"Organizing Group of the Antiphospholipid Antibody Treatment Trial. Am J Obstet Gynecol"}],"container-title":["Disease-a-Month"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011502903001706?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011502903001706?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,13]],"date-time":"2021-06-13T15:06:01Z","timestamp":1623596761000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0011502903001706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":161,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["S0011502903001706"],"URL":"https:\/\/doi.org\/10.1016\/j.disamonth.2003.10.001","relation":{},"ISSN":["0011-5029"],"issn-type":[{"value":"0011-5029","type":"print"}],"subject":[],"published":{"date-parts":[[2003,12]]}}}